These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 28811199

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Assessment of Brain Glucose Metabolism Following Cardiac Arrest by [18F]FDG Positron Emission Tomography.
    Zhang HJ, Mitchell S, Fang YH, Tsai HM, Piao L, Ousta A, Leoni L, Chen CT, Sharp WW.
    Neurocrit Care; 2021 Feb; 34(1):64-72. PubMed ID: 32358767
    [Abstract] [Full Text] [Related]

  • 27. Cerebellum-specific 18F-FDG PET analysis for the detection of subregional glucose metabolism changes in spinocerebellar ataxia.
    Oh JS, Oh M, Chung SJ, Kim JS.
    Neuroreport; 2014 Oct 22; 25(15):1198-202. PubMed ID: 25144395
    [Abstract] [Full Text] [Related]

  • 28. Estimating the input function non-invasively for FDG-PET quantification with multiple linear regression analysis: simulation and verification with in vivo data.
    Fang YH, Kao T, Liu RS, Wu LC.
    Eur J Nucl Med Mol Imaging; 2004 May 22; 31(5):692-702. PubMed ID: 14740178
    [Abstract] [Full Text] [Related]

  • 29. Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.
    Akman CI, Provenzano F, Wang D, Engelstad K, Hinton V, Yu J, Tikofsky R, Ichese M, De Vivo DC.
    Epilepsy Res; 2015 Feb 22; 110():206-15. PubMed ID: 25616474
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impact of EEG-vigilance on brain glucose uptake measured with [(18)F]FDG and PET in patients with depressive episode or mild cognitive impairment.
    Guenther T, Schönknecht P, Becker G, Olbrich S, Sander C, Hesse S, Meyer PM, Luthardt J, Hegerl U, Sabri O.
    Neuroimage; 2011 May 01; 56(1):93-101. PubMed ID: 21276863
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evaluation of Atlas-Based Attenuation Correction for Integrated PET/MR in Human Brain: Application of a Head Atlas and Comparison to True CT-Based Attenuation Correction.
    Sekine T, Buck A, Delso G, Ter Voert EE, Huellner M, Veit-Haibach P, Warnock G.
    J Nucl Med; 2016 Feb 01; 57(2):215-20. PubMed ID: 26493207
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Usefulness of FDG-PET in the diagnosis of patients with chronic severe brain injury].
    de la Cueva L, Noé E, López-Aznar D, Ferri J, Sopena R, Martínez C, Chirivella J, Abreu P, Uruburu E.
    Rev Esp Med Nucl; 2006 Feb 01; 25(2):89-97. PubMed ID: 16759614
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.